Alentis Therapeutics Ag
Clinical trials sponsored by Alentis Therapeutics Ag, explained in plain language.
-
New cancer drug targets specific protein in advanced tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called ALE.P03 in adults with advanced or spreading cancers that have a specific protein marker (CLDN1+). The study aims to find a safe and effective dose and see if the drug can shrink tumors. It will enroll 180 patients with cancers …
Phase: PHASE1, PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for protecting kidneys in serious autoimmune attack
Disease control Recruiting nowThis study is testing a new drug called ALE.F02 to see if it can help protect and preserve kidney function in people with a serious autoimmune disease called ANCA-associated vasculitis (AAV), which attacks the body's small blood vessels, especially in the kidneys. Researchers wil…
Phase: PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New 'Smart Bomb' drug targets tough cancers in major trial
Disease control Recruiting nowThis study is testing a new experimental drug called ALE.P02 for adults with advanced squamous cell cancers that have spread or can't be removed by surgery. The drug is designed to target cancer cells that have a specific marker called Claudin-1. Researchers will first find the s…
Phase: PHASE1, PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC